We report the generation and metabolic characterization of a newly CRISPR/Cas9-generated global Mct8/Oatp1c1 dKO mouse, and demonstrate that this mouse mimics a variety of key hallmarks seen in patients with AHDS. This evidence concerns the gene SLC16A2 and Allan-Herndon-Dudley syndrome.